AMPLIFY DISCOVERY
Adaptive Biotechnologies Corporation
Trademark Registered: 2019-09-17
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86459428 |
| Registration Number | 5863363 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Hoang-chi Truong |
| Attorney Docket Number | 10214-00502- |
| Law Office Assigned | L40 |
| Employee Name | WILKE, JOHN |
Timeline
| 2014-11-19 | Application Filed |
| 2018-01-01 | Date of First Use |
| 2018-06-05 | Published for Opposition |
| 2019-08-14 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-09-17 | Status: Live/Registered |
| 2019-09-17 | Trademark Registered |
| 2019-09-17 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Adaptive Biotechnologies Corporation |
| Address | 1551 Eastlake Avenue E, Suite 200 Seattle WA 98102 |
| Legal Entity Type | Corporation |
| Legal Entity State | WA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | Medical services, namely, diagnostic services for the diagnosis and treatment of cancer, auto-immune conditions, and infection diseases; medical services, namely, providing immune repertoire sequencing, analytic, and diagnostic services for developing assays for patient treatment; providing immune sequencing, analytic and diagnostic services for identifying prognostic and diagnostic biomarkers; providing immune sequencing, analytic, and diagnostic services for development of cancer treatments |
| GS0441 | Medical services, namely, diagnostic services for the diagnosis and treatment of cancer, auto-immune conditions, and infection diseases; medical services, namely, providing immune repertoire sequencing, analytic, and diagnostic services for developing assays for patient treatment; providing immune sequencing, analytic and diagnostic services for identifying prognostic and diagnostic biomarkers; providing immune sequencing, analytic, and diagnostic services for development of cancer treatments |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2014-11-22 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-11-26 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2015-03-09 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2015-03-10 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2015-03-10 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2015-03-10 | 6 GNRN O:Outgoing Correspondence |
| TEAS PETITION TO REVIVE RECEIVED | 2015-09-11 | 7 PROA I:Incoming Correspondence |
| PETITION TO REVIVE-GRANTED | 2015-09-11 | 8 PETG O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-09-11 | 9 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-09-11 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-09-11 | 11 TEME I:Incoming Correspondence |
| NOTICE OF REVIVAL - E-MAILED | 2015-09-11 | 12 NREV E:E-Mail |
| SUSPENSION LETTER WRITTEN | 2015-09-15 | 13 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2015-09-15 | 14 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2015-09-15 | 15 GNS3 O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2016-03-18 | 16 ALIE A:Allowance for Publication |
| NON-FINAL ACTION WRITTEN | 2016-03-21 | 17 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2016-03-21 | 18 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-03-21 | 19 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-09-21 | 20 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-09-21 | 21 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-09-21 | 22 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2016-10-03 | 23 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2016-10-03 | 24 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2016-10-03 | 25 GNS3 O:Outgoing Correspondence |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2017-04-03 | 26 RCSC S: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-10-03 | 27 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2017-10-06 | 28 PREV O:Outgoing Correspondence |
| WITHDRAWN FROM PUB - OG REVIEW QUERY | 2017-10-24 | 29 PBCR Z:Deletion |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2017-10-26 | 30 ZZZX Z:Deletion |
| NON-FINAL ACTION WRITTEN | 2017-10-27 | 31 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-10-27 | 32 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-10-27 | 33 GNRN O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2018-02-13 | 34 TCCA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-04-24 | 35 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-04-24 | 36 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-04-24 | 37 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-04-25 | 38 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2018-05-02 | 39 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-05-16 | 40 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-06-05 | 41 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-06-05 | 42 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-07-31 | 43 NOAM E:E-Mail |
| TEAS REQUEST TO DIVIDE RECEIVED | 2018-08-08 | 44 ERTD I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2018-08-30 | 45 AITU A:Allowance for Publication |
| DIVISIONAL REQUEST RECEIVED | 2018-08-08 | 46 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2018-08-30 | 47 DPCC D:Assigned to Examiner |
| CORRECTED NOA E-MAILED | 2018-08-31 | 48 NOAC E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-01-17 | 49 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2019-01-17 | 50 EXT1 S: |
| EXTENSION 1 GRANTED | 2019-01-17 | 51 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-01-19 | 52 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2019-07-26 | 53 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2019-07-26 | 54 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2019-08-06 | 55 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2019-08-14 | 56 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2019-08-15 | 57 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2019-09-17 | 58 R.PR A:Allowance for Publication |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 AMPLIFY DISCOVERY 86984100 5581247 Live/Registered |
Adaptive Biotechnologies Corporation 2014-11-19 |
 AMPLIFY DISCOVERY 86459428 5863363 Live/Registered |
Adaptive Biotechnologies Corporation 2014-11-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 